MACY, Neb. — Erica Carter is passionate about her job, and she has seven acres of flowers and vegetables to show for it. Carter’s specialty is reeling in grants to support students in the Omaha Nation school district, where she is a finance manager. One paid for the garden that sits next to the district’s…
Letters to the Editor is a periodic feature. We welcome all comments and will publish a selection. We edit for length and clarity and require full names. Work Requirements Unfairly Burden Medicaid Applicants Great story (“A Deloitte-Run System Denied Medicaid Benefits for Michigan’s Disabled. Now Trump’s Law Piles On,” July 21). However, a key point was missed. The…
By MATTHEW HOLT Strap in for the tale of why your hero is spending most of his life down YouTube rabbit holes of cardiology videos while blundering his way around many many medical centers and exposing many problems with American health care even before he gets close to the operating table. Yes it’s Matthew Holt’s…
The 1842 Fund launched a new startup called Suvi Health, which is developing an ambient AI platform that records hospital bedside conversations and turns them into a shared task list for patients and families. The company will pilot the tool with Mayo Clinic starting next month. The post New Startup Launches to Close the Bedside…
A new survey finds that employers are moving away from the Big Three PBMs while prioritizing healthcare affordability and transparency. The post Report: Employers’ Use of Big Three PBMs Falls in 2026 appeared first on MedCity News.
Executives told investors that the company’s finances are in better shape and the market for deals is warming up. Q2 results were helped by a “broad-based” improvement in demand for nurses.
AI can streamline outdated workflows, but health systems need to rethink what’s necessary before automating it.
ECG Management Consultants’ Nathan McCarthy says smaller health systems tend to focus on things that they know will have a meaningful short-term ROI
Deerfield Management formed Boulevard Bio with scientific co-founders Georg Schett and Frank Nestle. The startup’s lead program is in early clinical development for an autoimmune kidney disorder, and could offer dosing advantages over a recently approved Vera Therapeutics medicine and a Vertex Pharmaceuticals drug currently under FDA review. The post Startup Boulevard Bio Launches With…
While organizations have invested heavily in expanding ambulatory networks, many are discovering that operational workflows have not evolved at the same pace. The result is a growing gap between demand and the systems designed to manage it. The post Ambulatory Growth Demands a New Operating Model appeared first on MedCity News.